ANTO Therapeutics
Latest round
- Angel
Last raised
- Sep 2025
Total raised
- Undisclosed
Investors
- 4
About ANTO Therapeutics
Founded in 2023 and based in Wuxi, China, ANTO Therapeutics is a biotechnology company that focuses on the production of vivo lentiviral vector-based gene therapy drugs. It cooperated with research institutions, tertiary hospitals, and CROs (Contract customization research and development institutes). The team members have biomedical technology and industrial management experience. ANTO Therapeutics is a gene therapy and innovative delivery technology platform. The platform engages in vivo lentiviral vector-based gene therapy innovative drug programs. It has developed a fifth-generation lentiviral vector (5G vector) platform for in vivo gene therapy. Its product pipeline focuses on drugs for solid tumors and neurological tumors. The company generates revenue through develop lentiviral vector-based gene therapy innovative drug programs and sales of drugs for solid tumors and neurological tumors. The company will continue to develop its lentiviral gene therapy pipeline.
Who invested in ANTO Therapeutics
4 investors across 2 rounds
See all investors in ANTO Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ANTO Therapeutics
Who invested in ANTO Therapeutics?
ANTO Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ANTO Therapeutics raised?
ANTO Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ANTO Therapeutics last raise money?
ANTO Therapeutics's most recent round on record is a Angel, in Sep 2025.
What does ANTO Therapeutics do?
Founded in 2023 and based in Wuxi, China, ANTO Therapeutics is a biotechnology company that focuses on the production of vivo lentiviral vector-based gene therapy drugs.
Where is ANTO Therapeutics headquartered?
ANTO Therapeutics is headquartered in Hangzhou, China.
Which VCs invest in companies like ANTO Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at ANTO Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like ANTO Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.